Business · 26/10/2017
FDA Announces Public Meeting of Pharmacy Compounding Advisory Committee
The FDA is hosting a public meeting of the Pharmacy Compounding Advisory Committee to gather input on scientific, technical, and medical issues related to drug compounding under the FD&C Act, and to make recommendations to the Agency.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →